Coleman RE - Search Results

1

Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.

Reid DM, Doughty J, Eastell R, Heys SD, Howell A, McCloskey EV, Powles T, Selby P, Coleman RE. Reid DM, et al. Among authors: coleman re. Cancer Treat Rev. 2008;34 Suppl 1:S3-18. doi: 10.1016/j.ctrv.2008.03.007. Epub 2008 Jun 2. Cancer Treat Rev. 2008. PMID: 18515009

2

The clearance and bioavailability of pamidronate in patients with breast cancer and bone metastases.

Daley-Yates PT, Dodwell DJ, Pongchaidecha M, Coleman RE, Howell A. Daley-Yates PT, et al. Among authors: coleman re. Calcif Tissue Int. 1991 Dec;49(6):433-5. doi: 10.1007/BF02555856. Calcif Tissue Int. 1991. PMID: 1818770

3

Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).

O'Rourke NP, McCloskey EV, Rosini S, Coleman RE, Kanis JA. O'Rourke NP, et al. Among authors: coleman re. Br J Cancer. 1994 May;69(5):914-7. doi: 10.1038/bjc.1994.176. Br J Cancer. 1994. PMID: 8180023 Free PMC article.

4

Metabolic effects of pamidronate in patients with metastatic bone disease.

Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE. Vinholes J, et al. Among authors: coleman re. Br J Cancer. 1996 May;73(9):1089-95. doi: 10.1038/bjc.1996.210. Br J Cancer. 1996. PMID: 8624269 Free PMC article. Clinical Trial.

5

Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.

Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE. Vinholes J, et al. Among authors: coleman re. J Clin Oncol. 1997 Jan;15(1):131-8. doi: 10.1200/JCO.1997.15.1.131. J Clin Oncol. 1997. PMID: 8996134 Clinical Trial.

6

Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.

Vinholes J, Coleman R, Eastell R. Vinholes J, et al. Cancer Treat Rev. 1996 Jul;22(4):289-331. doi: 10.1016/s0305-7372(96)90021-3. Cancer Treat Rev. 1996. PMID: 9025785 Review. No abstract available.

7

High dose pamidronate: clinical and biochemical effects in metastatic bone disease.

Coleman RE, Purohit OP, Vinholes JJ, Zekri J. Coleman RE, et al. Cancer. 1997 Oct 15;80(8 Suppl):1686-90. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1686::aid-cncr20>3.3.co;2-t. Cancer. 1997. PMID: 9362437 Clinical Trial.

8

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease.

Vinholes JJ, Purohit OP, Abbey ME, Eastell R, Coleman RE. Vinholes JJ, et al. Among authors: coleman re. Ann Oncol. 1997 Dec;8(12):1243-50. doi: 10.1023/a:1008238422151. Ann Oncol. 1997. PMID: 9496390 Free article. Clinical Trial.

9

The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers. European Group for Serum Tumour Markers in Breast Cancer.

Robertson JF, Jaeger W, Syzmendera JJ, Selby C, Coleman R, Howell A, Winstanley J, Jonssen PE, Bombardieri E, Sainsbury JR, Gronberg H, Kumpulainen E, Blamey RW. Robertson JF, et al. Eur J Cancer. 1999 Jan;35(1):47-53. doi: 10.1016/s0959-8049(98)00297-4. Eur J Cancer. 1999. PMID: 10211087

10

Phase II study of docetaxel in patients with liver metastases from breast cancer. UK study group.

Coleman RE, Howell A, Eggleton SP, Maling SJ, Miles DW. Coleman RE, et al. Ann Oncol. 2000 May;11(5):541-6. doi: 10.1023/a:1008383707159. Ann Oncol. 2000. PMID: 10907946 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,031 results

Search Page

Filters